Genomic Valley Biotech Ltd vs Rites Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 37.71 as of 23 Oct 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Rites Ltd changed from 13.4 on March 2021 to 20.6 on March 2026 . This represents a CAGR of 7.43% over 6 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Rites Ltd changed from ₹ 5782 crore on March 2021 to ₹ 8439 crore on March 2026 . This represents a CAGR of 6.50% over 6 years The revenue of Genomic Valley Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Rites Ltd for the Jun '26 is ₹ 565.5 crore as compare to the Mar '26 revenue of ₹ 803.25 crore. This represent the decline of -29.6% The ebitda of Genomic Valley Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Rites Ltd for the Jun '26 is ₹ 147.96 crore as compare to the Mar '26 ebitda of ₹ 203.15 crore. This represent the decline of -27.17% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Rites Ltd changed from ₹ 90.44 crore to ₹ 97.78 crore over 9 quarters. This represents a CAGR of 3.53% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Rites Ltd changed from 73.62 % on March 2021 to 86.97 % on March 2026 . This represents a CAGR of 2.82% over 6 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Rites Ltd

Rites Dividend – History, Yield & Payout Overview Rites Overview RITES Limited is a Navratna, Schedule ‘A’ Central Public Sector Enterprise, established under the Ministry of Railways, Government of India, on 26 April 1974. The company is engaged in Design Engineering, Project Management Consultancy, Turnkey Construction, Export of Rolling Stocks, Locomotive Leasing, and Quality Assurance, serving multiple sectors including railways, highways, metros, bridges & tunnels, sustainability and green mobility, airports, land ports, ropeways, urban planning and infrastructure, ports and harbors, institutional buildings etc. It provides services of third party inspection, quality assurance, construction supervision & project management, operations & maintenance, leasing, export of rolling stock and modernisation of railways workshop projects, doubling and electrification on turnkey basis. Rites Dividend Payout Ratio The dividend payout ratio is the proportion of the net profit that is paid to the shareholders as dividends, with the remaining amount used for operational continuity or future expansion.
It serves as an indicator of how earnings are allocated between immediate shareholder returns and internal reinvestment. In the case of the Rites dividend payout, the ratio could indicate how the company is handling dividend payouts while keeping the financial flexibility to undertake consultancy and project execution work.
The ratio could fluctuate depending on the profit, capital, and public sector dividend rules. Rites Dividend Growth and Sustainability The Rites dividend history indicates that there is a correlation between the earnings and cash flows and the performance of dividends.
The growth and sustainability of dividends generally depend on a few factors, such as: Earning Stability: Consistent profitability from consultancy and project execution assignments can support periodic dividend declarations. Cash Flow Realisation: Timely receipt of payments from government or institutional clients may influence distributable surplus. Order Book Visibility: A strong pipeline of projects can provide revenue assurance, though execution risks may remain. Capital Allocation Norms: Government ownership guidelines for public sector enterprises can shape payout expectations in certain years. Taken together, these elements frame the long-term sustainability of distributions, as reflected in the broader Rites Ltd dividend history. How to Use Dividend Data for Investment Analysis? The Rites dividend yield may offer an initial perspective on income return relative to prevailing market valuation.
Dividend data is typically used alongside broader financial indicators: Review Earning Trends: Stable or growing profits generally provide support to dividend continuity. Assess Valuation Ratios: Metrics such as price-to-earnings and return on equity may indicate whether payouts are backed by efficient capital usage. Examine Balance Sheet Strength: Moderate leverage and adequate reserves can enhance resilience during cyclical slowdowns. Consider Sector Outlook: Infrastructure consultancy performance may be influenced by government spending patterns and policy priorities. A measured evaluation, therefore, combines payout metrics with profitability and valuation indicators, rather than relying solely on the dividend history of Rites Ltd. .

FAQs for the comparison of Genomic Valley Biotech Ltd and Rites Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Rites Ltd?

Market cap of Genomic Valley Biotech Ltd is 11 Cr while Market cap of Rites Ltd is 9,112 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Rites Ltd?

The stock performance of Genomic Valley Biotech Ltd and Rites Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Rites Ltd?

As of October 25, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹37.71. On the other hand, Rites Ltd stock price is INR ₹189.6.

How do dividend payouts of Genomic Valley Biotech Ltd and Rites Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Rites Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.